SAN FRANCISCO — The pharmaceutical industry’s most powerful lobbying group is opening its war chest to try to sway a policy fight with no clear connection to medicine or health care, spending a half-million dollars here to oppose a California ballot measure that would expand rent control protections across the state.

PhRMA’s contribution is unusual not for its size — $500,000 is a relatively small sum for the trade association — but because the group typically only involves itself in policy issues likely to impact its bottom line. In this fight, it is siding with landlords, developers, and real estate investors, mainly in California but with some headquartered in other states; PhRMA is the only large donor opposing the measure without ties to the housing industry.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • It is strange to see a Pharma Lobby involve itself in rent control.

    That said, it was even stranger, if possible, to see their foe Michael Weinstein squander AIDS funding on behalf of the 2017 Los Angeles city Measure S “Neighborhood Integrity Initiative”, to shut down essentially all housing development in Los Angeles. (Measure S was defeated 70%-30% by an unusually broad coalition of business supporters, trade unionists, and housing advocates.) Weinstein never was able to offer a coherent explanation why AIDS patients would benefit from housing shortages and soaring rents.

  • Who knew that unlimited money,and a corrupt political and medical system would lead to these unlikely partnerships. PHrMA, has it’s tendrils everywhere, manipulating the political process to settle scores or benefit their industry. One of the most heinous of all PHrMA activities it their wining and dining “education” of journalists, which is never disclosed. They infiltrate patient groups also under the guise of advocacy or spreading awareness. In Post Fact America, this deceptive, unscrupulous behavior, should really be illegal, but we are much too corrupt to even document or expose this corporate behavior. It is no wonder they can’t bring down pharmaceutical prices or even ask for scientific accuracy in the clinical trials. With our criminal administration, giving groups like PhrMA even more power to corrupt our political process, mislead consumers and plant misleading advertorials, and block any attempt to shed daylight on any of this, we are continuously being Gas Lighted.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy